OpenAlex
PricingAboutJobs
Log inGet started
Work

GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins

HTML

Year: 2020
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.0c00614
Authors: Robert J. Watson, Paul Bamborough, Heather Barnett, Chun-wa Chung, Rob Davis, Laurie Gordon, Paola Grandi, Massimo Petretich, Alex Phillipou, Rab K. Prinjha, Inmaculada Rioja, Peter Soden, Thilo Werner, Emmanuel H. Demont
Institutions: GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Germany)
Language: English

Topic: Protein Degradation and Inhibitors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: BET proteins, bromodomain inhibitors, selective inhibition, cell-permeable inhibitors, immunomodulation, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3045004415
FWCI: 3.938
Cites: 55
Cited by: 103
Related to: 10
Parts: 2
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security